Treatment of locally advanced prostate cancer (Stage T3)
Author:
Affiliation:
1. Department of Urology, Asahi General Hospital, Asahi
2. Department of Urology, Graduate School of Medicine, Chiba University, Chiba, Japan
Funder
Asahi General Hospital
Publisher
Oxford University Press (OUP)
Subject
Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,General Medicine
Link
http://academic.oup.com/jjco/article-pdf/47/3/257/26648806/hyw186.pdf
Reference27 articles.
1. The 2005 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma;Epstein;Am J Surg Pathol,2005
2. A new method of clsssifying prognostic comorbidity in longitudinal studies : development and validation;Charlson;J Chronic Dis,1987
3. Outcome of patients with localized prostate cancer treated by radiotherapy after confirming the absene of lymph node invasion;Suzuki;Jpn J Clin Oncol,2010
4. Preliminary results of o prospective randomized study comparing radical prostatectomy versus radical prostatectomy associated with neoadjuvant hormonal combination therapy in T2-3 N0 M0 prostatic carcinoma. The European Study on neoadjivant treatment of prostate cncer;Wities;Urology,1997
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Outcomes of radical prostatectomy in treatment of locally advanced prostate cancer: clinical observations;Cancer Urology;2023-02-28
2. Epigenome-wide DNA methylation and transcriptome profiling of localized and locally advanced prostate cancer: Uncovering new molecular markers;Genomics;2022-09
3. Increased expression of CD81 is associated with poor prognosis of prostate cancer and increases the progression of prostate cancer cells in�vitro;Experimental and Therapeutic Medicine;2019-11-26
4. Association between the molecular markers, effect and time of response to the androgen-deprivation therapy in patients with prostate cancer;Advances in molecular oncology;2019-04-28
5. TRIM16 transcription factor in prostate cancer;Bulletin of Siberian Medicine;2018-09-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3